Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UPLifT-Endo
NCT05903131Phase 2Recruiting
- Sponsor
- Washington University School of Medicine
- Start
- Oct 2024
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in Atypical endometrial hyperplasia (AEH) and endometrial cancer (EC) (2 arms), sponsored by Washington University School of Medicine. Primary endpoint: Number of participants with atypical endometrial hyperplasia (AEH)-free biopsy at 1 year. Started Oct 2024; status: recruiting.
02
Conditions
Atypical endometrial hyperplasia (AEH)endometrial cancer (EC)
Beyond the preview
Go deeper on NCT05903131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05903131.